Skip to main content
OpenTrials
Completed

NCT Number: NCT02430948

Improving Compliance With Medical Testing Guidelines

The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Cervical Cancer Colon Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Diseases, Male Genital Neoplasms, Female Genital Neoplasms, Male Intestinal Diseases Intestinal Neoplasms Lung Cancer Lung Diseases Lung Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Site Prostate Cancer Prostatic Diseases Prostatic Neoplasms Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms

Age range

30 year–89 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mount Sinai Beth Israel, New York, United States

Loading trial locations.

About this study

This study is a cluster randomized trial that compares the immediate post-encounter impressions of 12 physicians and 18 of their patients about the discussion of screening for breast, cervical, colorectal, lung and prostate cancer as well as their beliefs about screening efficacy and patient reports of the screening experience. The interventions are educational materials and academic detailing (educational outreach) for providers. The investigators are particularly interested in contrasting the patient and provider recollections, the differential impact on underuse and overuse compliance and whether patient behaviors are consistent with their stated screening plans.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients: healthy men and women ages 30-89 seeing their primary care provider for routine visit
  • Providers: non-pediatric primary care physicians from Mount Sinai Beth Israel or St. Luke's-Roosevelt associated practices

Exclusion criteria

  • Patient life expectancy of less than 1 year in primary care provider's judgment
  • Inability to read and understand English
  • Transgender status

Treatment and study plan

Color-coded materials

Other

A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation

Academic Detailing

Other

Educational outreach to address the rationale and data supporting recommendations for and against screening

Standard Support

Other

Screening recommendations presented in standard format

No academic detailing

Other

Physician receives study orientation for not the academic detailing curriculum

Primary outcomes

  1. Effect of educational intervention on providers' recommendations

    Time frame: Baseline

    Incidence of guidance compliance

  2. Effect of educational intervention on providers' recommendations

    Time frame: 3 months

    Incidence of guidance compliance

  3. Effect of educational intervention on providers' recommendations

    Time frame: 6 months

    Incidence of guidance compliance

  4. Effect of educational intervention on providers' recommendations

    Time frame: 12 months

    Incidence of guidance compliance

Secondary outcomes

  1. Patients' belief in the value of screening

    Time frame: Baseline

    measured by survey to be determined

  2. Patients' belief in the value of screening

    Time frame: 3 months

    measured by survey to be determined

  3. Patients' belief in the value of screening

    Time frame: 6 months

    measured by survey to be determined

  4. Patients' belief in the value of screening

    Time frame: 12 months

    measured by survey to be determined

  5. Patient compliance

    Time frame: Baseline

    measured by self- report in surveys to be determined

  6. Patient compliance

    Time frame: 3 months

    measured by self- report in surveys to be determined

  7. Patient compliance

    Time frame: 6 months

    measured by self- report in surveys to be determined

  8. Patient compliance

    Time frame: 12 months

    measured by self- report in surveys to be determined

Sponsors and collaborators

Lead sponsor

Beth Israel Medical Center

Other

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Apr 30, 2015
Registry last updated
Jul 26, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.